Sompo Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Sompo Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.33M	Sell	40,494 -4,060	-9%	-$233K	0.38%	51
2026 Q1	$2.7M	Buy	44,554 +4,390	+11%	+$256K	0.5%	48
2025 Q4	$2.17M	Sell	40,164 -1,680	-4%	-$80.8K	0.37%	50
2025 Q3	$1.89M	Sell	41,844 -5,460	-12%	-$255K	0.32%	53
2025 Q2	$2.19M	Sell	47,304 -1,390	-3%	-$68.2K	0.38%	49
2025 Q1	$2.97M	Buy	48,694 +3,980	+9%	+$232K	0.55%	44
2024 Q4	$2.53M	Sell	44,714 -5,066	-10%	-$283K	0.43%	53
2024 Q3	$2.58M	Buy	49,780 +15,140	+44%	+$710K	0.4%	52
2024 Q2	$1.44M	Sell	34,640 -2,900	-8%	-$130K	0.24%	66
2024 Q1	$2.04M	Buy	37,540 +850	+2%	+$43.3K	0.33%	58
2023 Q4	$1.88M	Buy	36,690 +660	+2%	+$34.6K	0.34%	60
2023 Q3	$2.09M	Sell	36,030 -37,790	-51%	-$2.32M	0.46%	56
2023 Q2	$4.72M	Buy	73,820 +6,700	+10%	+$449K	0.88%	30
2023 Q1	$4.65M	Sell	67,120 -1,090	-2%	-$76.9K	0.98%	29
2022 Q4	$4.91M	Buy	68,210 +1,690	+3%	+$127K	1.12%	23
2022 Q3	$4.73M	Sell	66,520 -16,610	-20%	-$1.2M	1.2%	21
2022 Q2	$6.4M	Sell	83,130 -22,300	-21%	-$1.7M	1.62%	16
2022 Q1	$7.7M	Buy	105,430 +680	+0.6%	+$45.7K	1.67%	11
2021 Q4	$6.53M	Buy	104,750 +29,590	+39%	+$1.74M	1.3%	20
2021 Q3	$4.45M	Buy	75,160 +40,070	+114%	+$2.64M	1.02%	30
2021 Q2	$2.35M	Buy	35,090 +3,540	+11%	+$231K	0.48%	66
2021 Q1	$1.99M	Sell	31,550 -38,200	-55%	-$2.38M	0.45%	71
2020 Q4	$4.33M	Buy	69,750 +550	+0.8%	+$33.8K	0.94%	37
2020 Q3	$4.17M	Buy	69,200 +360	+0.5%	+$21.7K	1%	33
2020 Q2	$4.05M	Sell	68,840 -13,110	-16%	-$784K	1.03%	32
2020 Q1	$4.57M	Sell	81,950 -43,030	-34%	-$2.63M	1.21%	29
2019 Q4	$8.02M	Sell	124,980 -4,290	-3%	-$246K	1.88%	15
2019 Q3	$6.55M	Buy	129,270 +12,420	+11%	+$584K	1.63%	22
2019 Q2	$5.3M	Buy	116,850 +1,830	+2%	+$85.2K	1.57%	22
2019 Q1	$5.49M	Sell	115,020 -24,520	-18%	-$1.22M	1.72%	20
2018 Q4	$7.25M	Buy	139,540 +60,860	+77%	+$3.27M	2.13%	15
2018 Q3	$4.88M	Sell	78,680 -2,560	-3%	-$152K	1.01%	37
2018 Q2	$4.5M	Sell	81,240 -80,643	-50%	-$4.36M	1.02%	38
2018 Q1	$10.2M	Sell	161,883 -17,680	-10%	-$1.14M	1.66%	23
2017 Q4	$11M	Sell	179,563 -74,940	-29%	-$4.69M	1.61%	22
2017 Q3	$16.2M	Buy	254,503 +5,030	+2%	+$294K	2.47%	7
2017 Q2	$13.9M	Sell	249,473 -52,597	-17%	-$2.86M	2.09%	10
2017 Q1	$16.4M	Buy	302,070 +31,840	+12%	+$1.75M	2.05%	9
2016 Q4	$15.8M	Buy	+270,230	New	+$14.8M	2.06%	8

Other funds holding BMY

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

ORIO

Old Republic International (ORI) Chicago, Illinois $2.67B AUM 26.94% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

UBP

Union Bancaire Privee Geneva 1, Switzerland $9.16B AUM 31.4% 1-Year Est. Return

Sompo Asset Management's BMY Position: Q2 2026 in Review

Sompo Asset Management reduced its Bristol-Myers Squibb (BMY) stake by 9.1% in Q2 2026, selling an estimated $233K and leaving 40,494 shares worth $2.33M. The position accounts for 0.38% of the portfolio, ranked #51.

Sompo Asset Management first reported a position in BMY in Q4 2016 and has held it in 39 quarters since. The position peaked at $16.4M in Q1 2017. 440 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Sompo Asset Management held 40,494 shares of Bristol-Myers Squibb worth $2.33M as of Q2 2026.
Sompo Asset Management sold 4,060 Bristol-Myers Squibb shares in Q2 2026, an estimated $233K.
Bristol-Myers Squibb made up 0.38% of Sompo Asset Management's portfolio in Q2 2026, its #51 holding.
Sompo Asset Management first reported a position in Bristol-Myers Squibb in Q4 2016 and has held it in 39 quarters since.
Sompo Asset Management's Bristol-Myers Squibb position peaked at $16.4M in Q1 2017.
440 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Sompo Asset Management's 13F filing for Q2 2026, filed 14 Jul 2026.